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ABSTRACT 
Setmar is a 3-exons gene coding a SET domain fused to a Hsmar1 transposase. Its 
different transcripts theoretically encode 8 isoforms with SET moieties differently spliced. 
In vitro, the largest isoform binds specifically to Hsmar1 DNA ends and with no specificity 
to DNA when it is associated with hPso4. In colon cell lines, we found they bind specifically 
to two chromosomal targets depending probably on the isoform, Hsmar1 ends and sites 
with no conserved motifs. We also discovered that the isoforms profile was different 
between cell lines and patient tissues, suggesting the isoforms encoded by this gene in 
healthy cells and their functions are currently not investigated. 
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INTRODUCTION 
Setmar is one of the 52 neogenes identified in the human genome that originate from a 
DNA transposon [Supplementary Table S1], i.e. from the exaptation of an open reading 
frame (ORF) encoding a transposase, the enzyme is able to carry out all the DNA 
cleavage and strand transfer steps required for the transposition of this kind of 
transposable element (TE) [1]. Setmar appeared about 40-58 million years ago in the 
anthropoid lineage at the origin of the hominoids and the old and new world monkeys [2]. 
The gene is located on the human chromosome 3 (positions 4,292,212 to 4,328,658 in 
GRCh38/hg38) and arose from two neighboring genes, the first comprising two exons 
coding a lysine methyltransferase (SET) and the downstream second coding a Hsmar1 
transposase (HSMAR1) belonging to the mariner family. Mariners are very simple TEs 
composed of one transposase ORF flanked by two inverted terminal repeats (ITRs). These 
flanking sequences are specifically bound by the transposase, that excises the TE from a 
'donor' site before catalysing its insertion at another ('target') locus. During evolution of the 
anthropoid lineage, the accumulation of at least three mutations modified the expression 
properties of the SET and HSMAR1 genes. They acquired the ability to be transcribed in a 
single RNA transcript in which the SET domain can be N-terminally fused to the Hsmar1 
moiety after intron excision to produce the SETMAR protein (also called Metnase) [2]. 
Recent work on Setmar RNA transcript variants isolated from the hematologic neoplasms 
of patients [3] and mRNA sequences available in databases revealed a complex situation. 
Alternative transcripts have the potential to code for two SET isoforms (V4 and X4) and 
eight SETMAR isoforms ranging from 40 to 78 kDa, although only the largest SETMAR 
isoform contains a complete SET moiety (Figure 1, Supplementary Table S2 and data S1). 
The eight SETMAR transcripts originate from alternative transcription start sites located 
upstream, within or downstream of the region encoding the SET domain, together with 
alternative splicing in the second exon of the SET moiety. Other variants resulting from 
single nucleotide polymorphisms can be found in human populations ([3] and 
http://databases.lovd.nl/whole_genome/view/SETMAR). The detection of SETMAR in 
various colorectal [4], melanoma, breast cancer (Supplementary Figure S1), and 
leukaemia cell lines [5] confirmed that only five transcript variants were translated into 
protein isoforms (Figure 1, V1, V2, X2, V5 and an isoform with a molecular weight (MW) 
similar to that of HSMAR1), although differences exists from one cell line to another [4]. To 
our knowledge, it is not established which protein isoforms are present in healthy and 
cancerous tissues of patients. 
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Since a decade, significant efforts have been carried out to elucidate the enzymatic 
activities of the SET and HSMAR1 moieties, to identify cellular protein partners, and to 
integrate this knowledge in biological pathways. In summary, the SET moiety was 
associated with the dimethylation of histone 3 lysines 4 and 36 [6] and the methylation of 
lysine 130 of the splicing factor snRNP70 [7]. The N-terminal domain of the HSMAR1 
moiety has kept its ability to bind specifically to the ITRs of the Hsmar1 transposon in vitro. 
Its C-terminal domain displays most of the cleavage and strand transfer activities of 
mariner transposases, except that the 3' second strand cleavage at the outer ITR ends is 
severely affected by a mutation of the catalytic triad (DDN instead of DDD) [8,9]. SETMAR 
has an additional DNA binding activity, in the form of a stable complex with the hPso4 
protein [10,11], that is able to bind in vitro to non-ITR double-stranded DNA target. To date, 
it is not clear whether the different SETMAR isoforms can bind to chromosomal DNA in 
human cells and whether they target specific Hsmar1 ITR related sequences and-or non-
ITRs. From a functional standpoint, the biological activities of the SETMAR V1 domains 
(Figure 1) have been documented in the context of at least three housekeeping 
mechanisms, where the protein enhances chromosomal decatenation [12,13], improves 
the efficiency and the accuracy of DNA repair by non-homologous end-joining [14-17], and 
positively impacts the restart of stalled replication forks after DNA damage repair [18]. 
Interestingly, SETMAR V1 is also able to enhance the chromosomal integration of 
transfected DNA fragments [19] and of lentiviral DNA into host cells genome [20]. However, 
the precise molecular mechanism is unknown and whether the choice of integration sites 
is governed by the binding properties of SETMAR is still an open question. Also, it is not 
clear whether (and how) this mechanism is connected to metastatic processes, by 
mediating integration of the free DNA released by tumor cells into the chromosomal DNA 
of healthy cells [21,22]. 
Here, we derived the DNA binding landscape of several SETMAR isoforms in the 
colorectal cell lines SW48 and HT29. These lines display specific expression profiles of 
SETMAR isoforms: HT29 cells express a single SETMAR isoform (V2) whereas SW48 
cells express several (V1, V2, X2, V5 and HSMAR1) [4]. We also revisit the annotation of 
the human genome for the Hsmar1 element and its associated 80-pb miniature element, 
MADE1, using logol [23] and BLAST+, and we could detect and annotate ~2500 novel 
MADE1 copies. We found that SETMAR binding sites occur mostly at MADE1 sequences, 
although a significant fraction of them (up to ~50%) can also be found at unannotated 
regions. In addition, we document the expression profile of SETMAR isoforms in healthy 
and cancerous colorectal tissues. Strikingly, X2 and V2 are the only SETMAR isoforms 
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expressed in both healthy and cancerous colon biopsies. We discuss which SETMAR 
isoforms are found in healthy tissues and tumors, with respect to the interest to study this 
protein in cancerous lines. 
 
MATERIALS AND METHODS 
Culture of cell lines 
HeLa cells, human colorectal cancer cell lineages (SW48, SW403, HT29), human 
melanoma cell lineages (BRIS, SK-MEL28and 518-A2), and human breast cancer cell 
lineages (MCF7, MDA-MB231, SKBR3 and T47D) were all cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10 % fetal bovine serum (FBS), at 37 °C and 
with 5 % CO2. HeLa cell transfection with 1 µg of pVAX-HSMAR1 DNA was monitored as 
described [4]. 
 
Samples of non-tumoral and tumoral colon tissues 
Two samples of colon tissues, tumoral and adjacent non-tumoral tissues, were recovered 
from patients after surgery for a colorectal cancer in 2007 or 2008. Samples were stored at 
-80°C by the tumor bank of the Tours CHRU. Patients were informed of the possibility of 
the use of levies for research and their agreement to participate in this research was 
collected. Selected samples did not display more than 50% of tumoral cells 
(Supplementary Table S3). 
 
Protein extraction from non-tumoral and tumoral colon tissues 
Tissue slices (10 µm) were generated with a cryomicrotome on frost samples of tumoral 
and non-tumoral tissues, and stored at -80°C. For each patient, protein lysates were made 
by suspending a tenth of slices in iced RIPA buffer (20 mM Tris-HCl pH7.2, 150 mM NaCl, 
1 mM EDTA, 1% Glycerol, 1% Triton X100, 0.5% doxycholate, 0.1% SDS, 1X-Complete 
Protease Inhibitor Cocktail (Roche Applied Sciences, Meylan, France)), vortexed for 1 min, 
incubated on ice for 15 min, centrifuged at 15,000 g for 15 min at 4°C. After recovery of 
supernatants, proteins were quantified with a Quick Start™ Bradford Protein Assay (Bio-
Rad, Richmond, USA) and conserved at -20°C. 
 
Antibody purification 
not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which was. http://dx.doi.org/10.1101/115030doi: bioRxiv preprint first posted online Mar. 9, 2017; 
Antoine-Lorquin et al. 6 
Murine pre-immune and anti-HSMAR1 polyclonal sera were produced by DNA vaccination 
using ICANtibodiesTM technology (In Cell Art, Nantes, France) as described [4]. Polyclonal 
antibodies (pA) contained in pre-immune and anti-HSMAR1 murine sera were purified 
using Protein A/G MagBeads (GenScript, Piscataway, USA). Their quality was then 
verified by polyacrylamide gel electrophoresis (PAGE) after staining with Coomassie blue 
and their concentration was defined using the BCA Protein quantification Kit (Interchim, 
Montluçon, France). 
 
PAGE, immunoblotting, and hybridization of antisera 
Protein extracts from cultured cells, PAGE, transfer onto a polyvinylidene difluoride (PVDF) 
membrane, antibodies incubations and imaging with a FUJI LAS4000 imager were carried 
out as described [4]. 
 
ChIP experiments 
Chromatin samples were prepared from non-synchronous and exponentially growing 
SW48 and HT29 cells. Chromatin shearing was performed with a Bioruptor ultrasonicator 
(Diagenode, Belgium). Chromatin immunoprecipitation was performed with 10 µg of 
purified pre-immune or HSMAR1 pA, and purification of immunoprecipitated DNA was 
done using the iDeal ChIP-Seq kit following supplier's recommendations (Diagenode, 
Ougrée, Belgium). Libraries for Illumina sequencing were made using iDeal ChIP-Seq & 
Library Preparation Kit (Diagenode, Ougrée, Belgium). DNA quantities were monitored at 
various steps of the procedure with the Qubit® dsDNA HS Assay Kit (Molecular probes, 
Eugene, USA). Fragment size selection, library quality control and Illumina sequencing 
(HiSeq 51 nucleotides, TruSeq SBS Kit v3 (Illumina, Fulbourn, United Kingdom)) were 
achieved at the Imagif sequencing platform (CNRS, Gif-sur-Yvette, France), following 
published quality recommendations [24]. Data published in this paper are based on three 
biological replicates. 
 
ChIP-Seq Analyses 
ChIP-Seq sequence reads were mapped to the human genome assembly hg38 
(December 2013; available at http://www.ncbi.nlm.nih.gov/assembly/GCF_000001405.26) 
with the Bowtie short read aligner [25]. Peak calling was done with the peak-calling 
prioritization pipeline (PePr1.1.5) [26] from bam files, and normalized over input (three 
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biological replicates). 
 
Data analyses 
Annotation of Hsmar1 and MADE1 copies in hg38 is described in Supplementary data 2. 
Unique or intersecting annotations were computed using bedtools. Ontologies and search 
for conserved motifs were carried out with GLAM2 [27], the GREAT pipeline [28], and the 
RSAT pipeline [29,30]. Data analyses and most graphic representation were done with R 
(https://www.r-project.org/). Graphic representations of chromosomes in the hg38 genome 
model were performed using svg files calculated with the DensityMap software at 
http://chicken-repeats.inra.fr/launchDM_form.php and gff files parameterized as 
recommended [31] in order to supply the chromosomes sizes, the locations of centromers, 
and a suitable description of the third field, i.e. the features in column 3. The locations of 
each centromer in chromosomes of the hg19 model were recovered and updated with 
liftover at the UCSC web site. 
 
Data repository 
All raw and processed data are available through the European Nucleotide Archive under 
accession number PRJEB19196. The gff files describing the updated annotation of 
Hsmar1 and MADE1 copies in the hg38 release and the ChIP-Seq peaks were supplied as 
Supplementary data 3 and 4.  
 
RESULTS 
SETMAR binding sites along human chromosomes 
Chromosomal targets of SETMAR were identified by ChIP-Seq on cell lines HT29 and 
SW48, using a custom made polyclonal antibody directed against the HSMAR1 domain of 
SETMAR. The specificity of this key antibody has been addressed previously which 
showed a good specificity/sensitivity ratio [4]. Our experience is that none of the 
commercial monoclonal and polyclonal antibodies commercially available and directed 
against the HSMAR1 domain are efficient are for ChIP experiments. ChIP-Seq of pan-
HSMAR1/SETMAR was preferred to transient transfection of plasmids expressing 
individual SETMAR isoforms because transfected cell populations typically display 
heterogeneous expression levels that can span three orders of magnitude. This may not 
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reflect the expression levels found in vivo [33] and can have strong impact on the binding 
landscape. Indeed, HSMAR1 and SET were found to accumulate at nucleoli (or peri-
heterochromatin) when overexpressed in HeLa [33] and other cell lines 
(http://www.proteinatlas.org/ENSG00000170364-SETMAR/subcellular). Overall, we found 
4366 and 8425 binding sites (BS) in HT29 and SW48 cells, respectively. Taking into 
account that in a few cases, peaks found in one cell type were split into two in the other, 
there is a total of 3513 peaks in common, together with 796 and 4908 only found in HT29 
or SW48 cells. 
Unfortunately, defining the co-occurrence of SETMAR BS with Hsmar1 and MADE1 copies 
proved to be difficult, mainly because of their limited description in hg38 genome 
annotation. TEs annotation is notoriously difficult to carry out and it is not uncommon to 
assess its quality and re-annotate a particular family/subfamily. The quality of the 
RepeatMasker annotation was therefore verified and improved using logol and BLAST+ 
(Supplementary data 2). We produced a revised annotation describing 519 Hsmar1 copies 
(displaying to 615 ITRs), together with 10295 MADE1 copies composed of 1875 full-length 
elements, 6246 elements truncated at one end (displaying a single ITR), and 2174 
elements with damaged ITRs (outer ends lacking ≥ 5 nucleotides). 
Intersections between ChIP-Seq peaks and the Hsmar1 or MADE1 copies were calculated 
with bedtools using default parameters. Overall, there are 3549 (~83.9%) and 3998 
(~49.6%) BS at Hsmar1 or MADE1 copies in HT29 and SW48 cells, respectively, the vast 
majority of which (78.5%, 3449/4396) is common to both cell lines. Binding occurs mostly 
at MADE1 elements compared to Hsmar1 ITRs, in both cell lines (Table 1). This result is 
consistent with the fact that SETMAR V2 is expressed in both cell lines (and likely other 
isoforms as well, in SW48 cells) and can bind to MADE1 and Hsmar1 DNA in vivo. A total 
of 456 Hsmar1 and 6062 MADE1 copies are not bound by SETMAR. We thus asked 
whether these copies were associated with lamina (LAD) or nucleolus (NAD) associated 
domains ([34] and http://biorxiv.org/content/early/2016/05/24/054908), but we could find no 
statistical correlation. Similarly, we could not find any association with intergenic regions, 
genes body, 5' proximal and 3' distal region of genes and introns. 
We next characterized the BS common to both cell lines and overlapping with truncated 
MADE1 copies. Since they are composed of a single ITR, they minimize the confounding 
effect of nearby peaks. BS are centered on a sequence corresponding to positions 5 to 26 
of Hsmar1 and MADE1 ITRs (Figure 2a, Supplementary data 2). We note, however, that 
while residues located at position 8 to 17 and 21 to 26 are critical for HSMAR1 binding in 
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vitro [2, 35], the conserved CG dinucleotide located at positions 24 and 25 appears less 
common at the genomic DNA level. On average, BS display 92.8 ±3.8% identical residues 
with the MADE1 consensus. In contrast, we found more sequence diversity in unbound 
MADE1 sequences, with an average of 87.8 ±5.2% identical residues.  
Thus, our results support well the fact that SETMAR V2 (and likely of other isoforms) 
binding to MADE1 and Hsmar1 DNA depends on the sequence conservation of their ITR, 
but it also depends on cell specific host factor(s). 
 
Features of non-ITR binding targets along human chromosomes 
The number of BS outside of Hsmar1 or MADE1 copies was higher in SW48 than in HT29 
cells, which correlated with the presence of four other SETMAR isoforms in SW48 (V1, X2, 
V5 and HSMAR1) that were dramatically more abundant than or absent in HT29 cells. On 
average, these BS are associated to lower q-values and smaller widths than those found 
at Hsmar1 or MADE1 DNA BS in HT29 and SW48 cells (Supplementary Figure S2; Figure 
2b). Altogether, this suggests that they require a specific molecular machinery, which may 
be independent of the presence of hPSO4 in both cell lines, as this protein is present in 
similar amounts in both cell lines (Figure 3). 
Searches for common ontologies and conserved transcription factor (TF) BS were 
conducted using the GREAT pipeline with default parameters (Supplementary data 5). We 
could not find significant association between BS at Hsmar1/MADE1 sequences, gene 
function or their location with respect to genes. For BS located outside of Hsmar1/MADE1 
sequences, 200 of the 4783 these BS could be associated to genes involved in epithelia 
and mesenchymal stem cell biology. 
As expected in term of genomic distribution, BS localized at ITRs followed that of 
Hsmar1/MADE1 copies. Unexpectedly, however, more than 75% of the BS located outside 
of Hsmar1/MADE1 sequences were not distributed at random and were clustered in a 
limited number of regions, ranging from 1 to 20 Mbp, found in only 10 chromosomes 
(Figure 4). Although no common DNA motif could be found, BS characteristics and their 
genomic distribution along chromosomes certainly reflect the (direct or indirect) specific 
binding of some SETMAR isoforms to DNA or chromatin. We next searched for putative 
transcription factor binding motifs (TFBM) at BS located outside of Hsmar1/MADE1, with 
the RSAT pipeline (Supplementary data 5). We found a clear signature of EGR1 and-or 
MEF2 TFBM in 69% of them, suggesting possible physical interactions between the two 
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TFs and SETMAR isoforms. 
 
Expression of SETMAR isoforms in colon biopsies 
Due to the heterogeneity of SETMAR isoform profiles between cancerous cell lines ([4,13] 
and Supplementary Figure S1) and that the expression profiles of healthy tissues or 
cancerous tumors can drift in primary cultures as well as in established cell lines [36-38], 
the presence of SETMAR isoforms was probed in biopsies of non-tumoral and tumoral 
colon tissues from 26 patients affected by a colon cancer. As a control, we also used a 
colorectal biopsy from a patient with no colorectal disorder. In healthy and tumoral colon 
tissues, we found that four (V1, V2, V5 and HSMAR1) of the five isoforms present in HT29 
and SW48 cells were not detected but two other SETMAR isoforms, X2 and V3, were 
present (Figure 5a). The most abundant was the X2 isoform. Its expression level varies 
from 1 to 5-folds, depending on the nature of the biopsy, and the patient but not sex 
(Figure 5b). This isoform is also found in healthy tissues. The second protein, which was 
poorly expressed only in a few patients, has a molecular weight of 55 kDa that 
corresponds to the V3 isoform. Overall, the stark contrast between the SETMAR 
expression profile in vivo (healthy/cancerous tissues) and in vitro (established colorectal 
cell lines) shows that it is very sensitive to the cellular context. Interestingly, V2, X2 and V3 
isoforms likely have altered or no SET catalytic activity since important parts of this domain 
are missing in these isoforms. Thus, the resulting proteins would be equivalent to a 
HSMAR1 tagged with N-terminal peptides that might modulate their interactions with 
putative (chromatin) partners. 
 
DISCUSSION 
Our work shows for the first time that SETMAR binds at a variety of BS in vivo. As 
expected, binding occurs at the ITR of Hsmar1 and MADE1, but also occurs at other sites 
centered on GC-rich regions with no obvious conserved motif. Remarkably, in HT29 cells, 
V2 binding occurs despite abundant hPSO4 levels in the nucleus. Overall, this novel 
population of BS unlikely result from the direct binding of SETMAR to chromosomal DNA, 
but may be mediated by other protein partners, possibly EGR1 and/or MEF2, that would 
interact through the pre-SET and/or the HSMAR1 domain. 
The V2 isoform lacks intact SET and post-SET domains, which rules out indirect binding 
mediated by protein complexes involved in replication or DNA repair [3,5,18]. They would 
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therefore result from interactions with DNA binding proteins that were so far not described 
and which would occur with the pre-SET subdomain and/or the HSMAR1 domain. In 
SW48, because the X2 and V5 isoforms and HSMAR1 display no SET subdomains, it is 
likely that these proteins have interactions with chromosomal DNA that are similar to those 
of V2. Under this hypothesis, most of the peaks unrelated to Hsmar1 and MADE1 copies 
would therefore result from interactions between the V1 isoform and other protein partners, 
putatively EGR1 and MEF2. These peaks would likely not result from interactions between 
V1 and protein complexes involved in replication or DNA repair. Indeed, they are discrete 
and well defined, what is not expected in such interactions that are not specific in location 
in non-synchronized cell populations. 
Our work, although limited to a cohort of 26 human samples, already provides important 
new data. Remarkably, our results demonstrate that the study of SETMAR functions using 
cell lines is tricky, especially for the V1 isoform that was so far never described as being 
present in healthy organs or in tumors in vivo. Here, our study was limited to 26 patients in 
whom only the V3 and X2 isoforms were detected in non-tumoral and certain cancerous 
biopsies. Currently, we have analysed 20 cell lines derived from colorectal cancers (13; [4] 
and Figure 2A, lane 1), melanoma (3) and breast cancers (4) (Supplementary Figure S1). 
In none of them the V3 isoform was detected while the V5 isoform was found in 7 
colorectal lines. The V2 and V3 isoforms display both a damaged SET domain likely 
unable to bind to DNA. It is therefore reasonable to hypothesize that the ability of V3 to 
bind to chromosomal DNA is close to that of V2 and mainly occurred on ITR of Hsmar1 
and MADE1 copies. Currently, it cannot be discarded that most non-Hsmar1/MADE1 BS 
are due to the binding of V1, a SETMAR isoform that was so far only detected in a few cell 
lineages. 
Since HSMAR1 3' end cleavage activity is severely impaired [8], HSMAR1 and isoforms 
like V2, V3, X2 and V5 are unlikely to mediate Hsmar1/MADE1 excision. However, 
HSMAR1 is still capable of mediating 5' end cleavage and DNA integration [8,19]. This 
raises the interesting possibility that SETMAR isoforms might catalyse integration of extra-
cellular DNA, because circulating free DNA is often released from cell death or infection 
and can be passively transferred into cells [21,22]. Given the limited number of possible 
integration sites, mostly located outside of genes, SETMAR would then represent a 
nuclear mechanism protecting cells against the genotoxic effects of integration of 
circulating cell free DNA. This would represent a recent functional innovation, restricted to 
the anthropoid lineage.  
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Figure Legends 
Figure 1. Organisation of the Setmar gene (a) and the various isoforms resulting from its 
transcription (b). 
 
Figure 2. Graphic analyses of ChIP-Seq peak features. (a) Conserved motifs located by 
GLAM2 in truncated MADE1 copies overlapping or not with a ChIP-Seq peak. On the top, 
the SETMAR BS sequence in the MADE1 consensus sequence is shown, and below the 
sequence of the BS defined in vitro [2,35]. Positions along the ITR are indicated below the 
horizontal axes of Weblogos. The population of MADE1 without peaks was heterogeneous 
BS and since it is a mixture of elements with few conserved BS and elements with an 
ability to be bound by SETMAR isoforms that depends on the local chromatin structure. (b) 
Boxplots representing the distributions of the width (in bp) of peaks colocalizing with 
Hsmar1 or MADE1 ITRs (2 boxes on the right) or elsewhere in the human genome (2 
boxes on the left) depending on the cell lines (HT29 in blue, SW48 in red). 
 
Figure 3. Control of the hPso4 (also known as PRPF19) presence in HT29 and SW48 cell 
lines. Protein extracts (50 µg) were used to make Western blot. hPso4 and beta actin 
detections were achieved together using a rabbit anti-human hPso4 (PA5-24797, 
ThermoFischer Scientific) and a rabbit anti-human beta actin (EPR16769, Abcam) as 
primary antibodies and donkey anti-rabbit IgG-IR DYE800LT as a secondary antibody. 
Incubation with both antibodies were done overnight at 4°C in the Odyssey blocking buffer 
TBS (LI-COR). Three washings (10 min) of membranes were done in PBS1X, 0.1% triton 
X100, at room temperature after each antibody incubation. Membranes were analysed 
using an Odyssey CLx Imaging system (LI-COR). Protein molecular weights are indicated 
in the left margin. 
 
Figure 4. Distribution of gene densities, Hsmar1 and MADE1 copies and peaks in 
chromosomes of the hg19 genome model. (a) Graphic representation of the gene 
density, and the occurrences of MADE1 and Hsmar1 copies and ChIP-Seq peaks co-
localized with a Hsmar1 or a MADE1 copy along the human chromosomes. Each 
chromosome is represented from the left to the right in six columns: the gene density, the 
occurrences of MADE1 copies, the occurrences of Hsmar1 copies, the occurrences of 
ChIP-Seq peaks co-localized with a Hsmar1 or a MADE1 copy only in HT29 cells, both in 
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HT29 and SW48 cells, and only in SW48 cells. (b) Graphic representation of the gene 
density, and the occurrences of MADE1 and Hsmar1 copies and the ChIP-Seq peaks that 
were not co-localized with a Hsmar1 or a MADE1 copy along the human chromosomes. 
Each chromosome is represented from the left to the right in five columns: the gene 
density, the occurrences of MADE1 copies, the occurrences of Hsmar1 copies, the 
occurrences of ChIP-Seq peaks that did not co-localize with a Hsmar1 or a MADE1 copy 
only in HT29 cells, and only in SW48 cells. The most concentrated region of non-ITR 
binding targets in HT29 and SW48 is indicated with a light green bar. In both graphics, 
gene density and ChIP-Seq peaks were colourized using the colour scale 1, the 
occurrences of MADE1 and Hsmar1 copies used the colour scale 2. Densities and 
occurrences were calculated per window of 105 bp. The centromer of each chromosome is 
located by a constriction in the shape of each chromosome. 
 
Figure 5. Western blot analyses of SETMAR isoforms in healthy and tumorous colorectal 
tissues of patients. (a) Protein extracts of two biopsies from patient 12 (P12; healthy (H) 
and tumoral (T) tissues, 50 µg), SW403 cell line that mainly expresses V2 and X2 
SETMAR isoforms [4] (lane 1, 5 µg), HeLa cells (lane 2, 50 µg), HeLa cells transfected 
with pVAX-Hsmar1 (lane 3, 50 µg), and a colorectal biopsy from a patient with no 
colorectal disorder (lane 4, 50 µg). Molecular weights of isoforms are indicated in the left 
margin. (b) Protein extracts from healthy (H) and tumoral (T) tissue biopsies of 26 patients 
(P1 to P26). Actin is shown as an internal loading reference. The sex of each patient and 
the phenotype of their colon cancer (microsatellite stable (MSS) and microsatellite instable 
(MSI)) are indicated. For imaging the Western blot results with the anti-Hsmar1 antibodies 
in (a) and (b), an exposure time of 1 hour was used while only 5 to 10 minutes were 
required for the actin controls (Abcam, ab13822). Protein molecular weights are indicated 
in the left margin. 
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Table 1a. Number and location of ChIP-Seq peaks in two colorectal cell lines  
Binding sites HT29 cells  SW48 cells Common in both cell 
lines 
Hsmar1 19 21 123 
MADE1 197 710 3326 
Other 538 4082 163 
 
Table 1b. Proportion of Hsmar1 and MADE1 ITRs bound by SETMAR in two colorectal cell 
lines 
 HT29 SW48 
Proportion of Hsmar1 ITRs 
bound in hg38 
23.2 % 23.6 % 
Proportion of MADE1 ITRs 
bound in hg38 
34.2 % 39.7 % 
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